Success and safety of endoscopic treatments for concomitant biliary and duodenal malignant stenosis: A review of the literature

Table 1 Results of the studies in which endoscopic retrograde cholangiopancreatography and upper operative endoscopy for the treatment of bilio-duodenal malignant stenosis were performed

Ref.	Study design	Intervention	Patient (n)	Technical success n (%)	Clinical success n (%)	Adverse events
Kaw et al[12], 2003	Retrospective	Combined biliary and duodenal stenting	18 (18 concomitant)	17/18 (94.4)	16/17 (94.1)	None
Profili et al[12], 2003	Case series	Combined biliary and duodenal stenting	4 (4 concomitant)	4/4 (100)	4/4 (100)	In one case transient increase of amylase and lipase
Vanbiervliet et al[19], 2004	Prospective	Biliary stents were placed in patients previously treated with duodenal stents	18	17/18 (94.4)	17/18 (94.4)	None
Maire et al[13], 2006	Retrospective	Combined biliary and duodenal stenting	100 (23 with bilio-duodenal stenosis; 6 concomitant)	21/23 (91) (the study reports the overall technical success)	21/21 (100)	None
Mutignani et al[11], 2007	Prospective	Combined biliary and duodenal stenting	64 (14 concomitant)	10/14 (71.4)	Not reported only for the patients undergone concomitant bilio-duodenal stenting	Cholecistitis (1 patient): 10%
Moon et al[18], 2009	Prospective	Combined biliary and duodenal stenting	8 (8 concomitant)	8/8 (100) (Duodenal stent); 7/8 (87.5) (Biliary stent)	7/7 (100)	1/8 (12.5%) mild pancreatitis
Katsinelos et al[14], 2010	Retrospective	Combined biliary and duodenal stenting	39 (7 concomitant)	32/37 (82) (the study report the overall technical success)	Not reported only for the patients undergone concomitant bilio-duodenal stenting	3/32 (9.3%) post-sphincterotomy bleeding
Hamada et al[16], 2011	Retrospective	Combined biliary and duodenal stenting	18 (4 concomitant)	4/4 (100)	Not reported only for the patients undergone concomitant bilio-duodenal stenting	NR
Tonozuka et al[17], 2013	Retrospective	Combined biliary and duodenal stenting	11 (11 concomitant: 8 EUS-BD and 3 ERCP-BD)	3/3 (100)	3/3 (100)	No adverse events
Canena et al[15], 2014	Retrospective	Combined biliary and duodenal stenting	50 (15 concomitant)	13/15 (86.7)	Not reported only for the patients undergone concomitant bilio-duodenal stenting	Not reported only for the patients undergone concomitant bilio-duodenal stenting

ERCP: Endoscopic retrograde cholangiopancreatography; EUS: Endoscopic ultrasonography; BD: Biliary drainage.